A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma
Condition(s):Renal Cell CarcinomaLast Updated:March 15, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Renal Cell CarcinomaLast Updated:March 15, 2024Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:September 13, 2023Not yet recruiting
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:February 6, 2014Completed
Condition(s):Renal Cell CarcinomaLast Updated:April 5, 2017Completed
Condition(s):Renal Cell CarcinomaLast Updated:January 10, 2024Active, not recruiting
Condition(s):Renal Cell CarcinomaLast Updated:September 24, 2021Not yet recruiting
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:October 6, 2021Completed
Condition(s):Renal Cell CarcinomaLast Updated:August 30, 2021Completed
Condition(s):Renal Cell CarcinomaLast Updated:October 30, 2020Not yet recruiting
Condition(s):Renal Cell CarcinomaLast Updated:April 23, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.